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It has been reported that remarkable and sustained activation of astrocytes and/or microglia occurs in cancer
induced pain (CIP), which is different from neuropathic and inflammatory pain. The present study was designed to
investigate the role of spinal Toll-like receptor 4 (TLR4) induced glial neuroinflammation in cancer induced pain
using a modified rat model of bone cancer. The rat model of CIP consisted of unilateral intra-tibial injection with
Walker 256 mammary gland carcinoma. Nine days after Walker 256 inoculation, a robust activation of both
astrocytes and microglia in bilateral spinal dorsal horn was observed together with significant bilateral mechanical
allodynia. This neuroinflammation was characterized by enhanced immunostaining of both glial fibrillary acidic
protein (GFAP, astrocyte marker) and OX-42 (microglia marker), and an elevated level of IL-1β, IL-6 and TNF-α
mRNA. I.t. administration of fluorocitrate (an inhibitor of glial metabolism, 1 nmol) or minocycline (an inhibitor of
microglia, 100 μg) has significant anti-allodynic effects on day 12 after Walker 256 inoculation. Naloxone (a
nonstereoselective TLR4 signaling blocker, 60 μg, i.t.) also significantly alleviated mechanical allodynia and
simultaneously blocked the increased inflammatory cytokine mRNA. The results suggested that spinal TLR4 might
play an important role in the sustained glial activation that critically contributed to the robust and sustained spinal
neuroinflammation in CIP. This result could potentially help clinicians and researchers to better understand the
mechanism of complicated cancer pain.
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Cancer induced pain (CIP), especially derived from pri-
mary bone cancer or secondary bone metastases, is a
complicated clinical syndrome, which severely impairs
the quality of life of patients. Due to the lack of elucida-
tion of its mechanism, it still remains a serious medical
problem. In the past decades, several experimental mod-
els have been established which shed some light on the
mechanisms underlying CIP [1-4].
A remarkable and sustained activation of astrocyte
and/or microglia induced by unilateral tumor cell inocu-
lation has been reported in cancer induced pain models
[1,5]. Especially in peripheral neuropathic pain and in-
flammatory pain models, former research suggested that* Correspondence: wangyanqing@shmu.edu.cn
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reproduction in any medium, provided the orglial activation and the subsequent robustly increased
expression of proinflammatory cytokines critically con-
tribute to chronic pain [6].
Recently, we established a new model of CIP by inocu-
lation of mammary gland carcinoma cells Walker 256
into unilateral tibial cavity and observed bilateral mech-
anical allodynia [7]. Whether the above cellular and
molecular changes indicating a contribution of neuroin-
flammation are associated with CIP remains to be eluci-
dated in the present study.
There are numerous candidate neuron-to-glia signals
proposed for initiating glial activation, including neuro-
transmitters, neuromodulators and neuronally derived
chemokines among others [8]. A very intriguing mech-
anism has been recently proposed for spinal microglial
activation in response to peripheral nerve injury, that is,
activation of Toll-like receptors (TLRs) especially TLR4,
TLR3 and TLR2 [9-13]. It has been reported that TLR4ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[14,15]. TLRs are Type I membrane receptors which
recognize a variety of molecules derived from pathogens,
such as bacterial cell wall components [16-19]. In
addition, TLRs detect specific endogenous ligands,
mainly molecules released from damaged cells or extra-
cellular matrix breakdown products, which activate the
innate immune system, including fibrinogen, heat shock
proteins (HSP), mRNA, fibronectin, tenascin-C and so
on [20-23]. However, the receptor leading to glial activa-
tion in chronic pain models and especially in CIP still re-
main unidentified.
Hence, the present study was designed to characterize
the role of microglia and astrocyte activation dependent
spinal neuroinflammation in a rat model of CIP. The
results demonstrated that bilateral sustained activation
of spinal astrocyte as well as microglia critically contri-
butes to the bilateral mechanical allodynia induced byFigure 1 Tibia bone destruction by Walker 256 inoculation. Radiograp
Walker 256 inoculation. (A’-B’) showing the proximal end of the bones wit
tumor bearing rats 20 days after Walker 256 inoculation. (D) histology of tib
showing normal marrow cavity in PBS rats instead tumor cells in Walker 25unilateral bone cancer in rats. Spinal TLR 4 might play
an important role in the sustained activation of micro-
glial cells in CIP rats.Results
Bone destruction evaluation
At day 20 after Walker 256 inoculation, radiological
photographs showed that the Walker 256 inoculated
tibia bone displayed significant signs of radiolucent le-
sion in the proximal epiphysis, close to the inoculated
site (Figure 1A, B). However, no radiological changes
were observed in the tibia bone contralateral to Walker
256 inoculation. At the end of the experiment, rats were
sacrificed with an overdose of sodium pentobarbital and
the tibia bones were removed for histological analysis.
The Walker 256 inoculated tibia bone showed significant
tumor growth (Figure 1D) and the surface of bone washs of the Contralateral (A) and Ipsilateral (B) tibia bone 20 days after
h a higher magnification. (C) showing the tibia bone from normal and
ial bone destruction stained by Hematoxylin-eosin. The hollow arrow
6 inoculated rats. The black arrow indicates the trabecular bone.
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(Figure 1C).
Time course of pain-related behaviors induced by Walker
256 inoculation
At 4 days after unilateral Walker 256 inoculation into
the tibia bone, the rats displayed a profound decrease in
paw withdrawal threshold to von Frey hair stimulation.
This was not only observed in the paw ipsilateral to the
Walker 256 inoculated hind limb but also in the contra-
lateral hind limb that was not inoculated (p< 0.01). In
contrast, there was no significant difference in paw with-
drawal threshold between rats receiving an intra-tibial
injection of PBS or heat-killed Walker 256 cells, and
normal rats (p> 0.05) (Figure 2A). Using a radiant heat
test, we showed that there were no detectable differences
in thermal hyperalgesia between normal, PBS, heat-killed
Walker 256, and Walker 256 inoculated rats for bothFigure 2 Changes of mechanical response thresholds to von
Frey hair (A) and paw withdrawal latency to radiant heat (B) of
the ipsilateral and contralateral hind paw in normal rats and
Walker 256 (4 × 105 cells), heat-killed cells and PBS -inoculated
rats. Data are expressed as means ± SEM. *p< 0.05, **p <0.01 vs.
normal rats.hind paws during the whole experiment (p> 0.05)
(Figure 2B).
Hypertrophy of astrocytes and microglia in the spinal
cord
Immunohistochemical staining of GFAP and OX-42 was
used to evaluate the hypertrophy of astrocytes and
microglia in the spinal cord respectively. The average of
four sections per rats was analyzed in this study. The
immunohistochemical results showed that in control
rats, sporadic astrocyte moderately labeled by GFAP
with classic star-shape, and microglia labeled by OX-42
with classic ramified morphology, antler-like fine pro-
cesses and slender cytoplasm, are detected in both the
gray and white matters of the spinal cord (Figure 3A-B).
In the Walker 256 inoculated rats, a robust hypertrophy
of both astrocyte and microglia was observed in both
sides of spinal dorsal horn at 8 and 16 days after unilat-
eral inoculation as compared to the normal, PBS, and
heat-killed Walker 256 cells inoculated rats. The hyper-
trophic astrocytes and microglia turned to large cell
shapes with short and thick processes. Quantification by
an observer blinded for treatment showed that GFAP-
and OX-42-positive signals in both sides of the spinal
dorsal horn of Walker 256 inoculated rats were remark-
ably elevated in comparison to normal, PBS and heat-
killed cells inoculated rats (Figure 3D, E).
Changes in IL-1β, IL-6 and TNF-α mRNA expression in the
spinal cord
To determine the functional activation of spinal glia, the
expression of mRNA for the proinflammatory cytokines
IL-1β, IL-6 and TNF-α in the spinal dorsal horn was
analyzed using semi-quantitative RT-PCR. The results
showed that, at 8 days post-inoculation, the levels of IL-
1β, IL-6 and TNF-α mRNA in both sides of spinal dorsal
horn were elevated significantly in Walker 256 inocu-
lated rats (p< 0.05). No change in cytokine mRNA was
detected when comparing rats inoculated with PBS and
Heat-killed cells with normal rats (p> 0.05) (Figure 4A).
Furthermore, the levels of IL-1β, IL-6 and TNF-α mRNA
were further elevated at 16 post-inoculation in compari-
son to the normal rats (p< 0.05) (Figure 4B). Similarly,
the spinal level of IL-1β, IL-6 and TNF-α protein in
Walker 256 inoculated rats were significantly increased
at 12 days post Walker 256 inoculation (p< 0.05)
(Figure 4C). Therefore, in order to minimize the number
of animals needed, we only analyzed cytokine mRNA
levels in the spinal in subsequent experiments.
Role of spinal microglia activation in cancer induced pain
On day 12 after Walker 256 inoculation, the rats dis-
played stable mechanical allodynia, and also spinal astro-
cytes and microglia were observed to be significantly
Figure 3 Changes of expression of GFAP and OX-42 protein in the dorsal horn of the spinal cord detected by immunohistochemistry
after the rats received carcinoma cells. (A) and (B) showing representative images for GFAP and OX-42 immunostaining respectively. (C)
showing the selected area marked with red square in the spinal cord for quantification. (D, E) Quantification of astrocyte and microglia expression
in the spinal dorsal horn after intra-tibial inoculation of Walker 256. Percentages of immunostaining are expressed as mean± SEM (3 ~ 5 for each
group). **p <0.01 vs. normal rats.
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spinal glial hypertrophy in the present rat model of bone
cancer pain, we examined behavioral pain responses
after i.t. treatment with inhibitors of glial activity on day
12 after Walker 256 inoculation. The results showed that
i.t. injection of 1 nmol fluorocitrate (a glia metabolic in-
hibitor) or 100 μg minocycline (an inhibitor of microglial
activity) both significantly elevated mechanical thresh-
olds in both hind paws (p< 0.05) (Figure 5A, B). A sin-
gle i.t. administration of 10 μl normal saline or PBS/HCl
as a control had no effect on mechanical thresholds in
Walker 256 inoculated rats as compared to mechanical
thresholds before intrathecal administration (p> 0.05).
Role of Toll-like receptor 4 in cancer induced pain
A possible mechanism contributing to spinal glial activa-
tion is via stimulation of TLR4, a member of the TLR
family. It has been proposed that sensory neuron dam-
age leads to the release of TLR recognized signals and
consequently to stimulation of microglial TLR4, initiat-
ing microglial activation with release of proinflammatory
cytokines. RT-PCR analysis showed that the levels ofTLR4 in bilateral spinal dorsal horn were significantly
increased after unilateral inoculation of Walker 256 in
comparison to normal rats or rats inoculated with PBS
or heat-killed cells. Notably, the levels of TLR4 were
increased moderately at 8 days and markedly at 16 days
after Walker 256 inoculation (Figure 6A). Based on pre-
vious studies showing that naloxone effectively inhibits
the TLR4 signaling pathway [15,24,25], 60 μg of nalox-
one was administered through i.t. injection. The behav-
ioral test showed that, as compared to the i.t. normal
saline injection, a single i.t. administration with naloxone
significantly increased the mechanical thresholds of both
hind paws at 45 and 135 mins after intrathecal injection,
on 8 days after Walker 256 inoculation (Figure 6C). Fur-
ther RT-PCR analysis showed that i.t. naloxone treat-
ment significantly decreased spinal IL-1β and TNF-α
mRNA bilaterally 135 mins after intrathecal injection as
compared to rats treated with saline (Figure 6B).
Discussion
The main finding of the present study is the sustained
and bilateral activation of both spinal astrocyte and
Figure 4 Changes of inflammatory cytokines IL-1β, IL-6, TNF-α mRNA level detected by Semiquantitative RT-PCR analysis. (A) and (B)
showing the mRNA levels in spinal dorsal horn 8 days and 16 days after intra-tibial inoculation of Walker 256 respectively. The relative mRNA level
was expressed as a ratio relative to the normal control. *p< 0.05, **p< 0.01 vs. normal rats. (C) showing the protein level of IL-1β, IL-6, TNF-α in
the spinal dorsal horn at 12 days after Walker 256 inoculation. * p< 0.05, vs. PBS rats.
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into the tibia of rats. Moreover, the inhibition of glial ac-
tivation by i.t. injection of fluorocitrate or minocycline
both reduced the mechanical allodynia in rats with CIP.
These findings clearly demonstrate that spinal glial acti-
vation and sustained spinal neuroinflammation contrib-
ute to the development and maintenance of allodynia in
cancer induced pain. Further studies suggested that the
increased spinal TLR4 expression might play an import-
ant role in the sustained glial activation we observed in
our model of CIP.
According to a previously reported rat CIP model [2],
we established a modified rat model of cancer induced
pain by inoculating an alternative and available breast
cancer cell line, Walker 256 mammary gland carcinoma
cells, into the intra-tibial cavity of syngeneic female
Wistar rats via a new injection site [7]. In the present
study, no skin incision was made along the patellar liga-
ment to expose the tibia head and the carcinoma cells
were injected directly into the tibial cavity via knee
joint. This modification of the inoculation procedure
was made carefully to further minimize the damage to
the knee joint. The results demonstrated that the in-
oculation procedure per se did not affect basal behav-
ioral responses in the von Frey and radiant heat test
even on the early days after inoculation, indicating thatthe function of the knee joints was kept intact. How-
ever, our preliminary results indicate that the surgical
procedure may affect the general condition at the early
stage, showing the significant body weight loss at early
days after intra-tibial injection, even in PBS injected
rats. Therefore, we selected a later time point (as early
as the pain became stable) to analyze glia activation
and TLR4 expression.
Clinically, the severity of bone cancer induced pain,
which is usually induced by primary bone cancer or by
secondary bone metastases from e.g. breast, prostate or
lung cancer is closely correlated with the extent of bone
destruction. The pain progressively becomes heavy as
cancer growth and bone destruction in the affected bone
[26,27]. The present CIP model, using an intra-tibial
Walker 256 cell inoculation, is associated with ambula-
tory pain, mechanical allodynia and a reduction in
weight bearing on the ipsilateral hind limb indicating the
hypersensitivity of rats to pain [7]. Similar to most other
reported CIP models, thermal hyperalgesia was not
observed after Walker 256 cells inoculation. The present
results suggested that this modified model could also
mimic well the key features of human CIP.
Interestingly, in the present model of cancer induced
pain, the rats displayed mechanical allodynia in both
hind paws even though Walker 256 cells were inoculated
Figure 5 Anti-allodynic effects by intrathecal administration of
fluorocitrate (A) or minocycline (B). On 12 days after Walker 256
inoculation, fluorocitrate (1 nmol), a glia metabolic inhibitor, or
minocycline (100 μg), a kind of microglia activation inhibitor
significantly increased the mechanical thresholds to von Frey hair
stimulation 3 hrs after i.t. treatment. *p< 0.05 vs. normal saline
treatment; #p< 0.05 vs. before treatment.
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ence of bilateral pain-related behavior. Furthermore, we
observed a bilateral significant increase in the expression
of GFAP and OX-42 as well as proinflammatory cyto-
kines including TNF-α, IL-β, IL-6 mRNA. These obser-
vations indicate bilateral activation of both microglia
and astrocytes in the present bone cancer pain model.
This unique sustained bilateral activation of both micro-
glia and astrocytes in the present model of CIP is quite
different from what is observed in other cancer pain
models as well as in unilateral models of neuropathic
pain and inflammatory pain. In osteolytic sarcoma cell-
and mammary gland carcinoma cell-induced bone pain
models [1,2,28], remarkable and sustained activation of
astrocytes only was observed ipsilateral to cancer cells
inoculation. However, a sustained ipsilateral activation ofboth astrocyte and microglia 20 days after the inocula-
tion of prostate cancer cells was reported later [5]. This
apparent discrepancy illustrates the complexity of the
neuroinflammatory condition in the spinal cord induced
by different cancer cells in different animals and these
findings further remind us of the complexity of the
underlying mechanisms of cancer pain.
An early activation of spinal microglia and a delayed
activation of astrocytes, which in turn maintains long-
term pathological states such as persistent pain, have
been observed after peripheral nerve injury [29]. Hald
et al. compared the differential activation of spinal glial
cells in two murine models of cancer pain and one
model of neuropathic pain to investigate if microglial ac-
tivation is a general prerequisite for astrocyte activation
in pain models. These authors found that bone cancer
and sciatic nerve proximal cancer (developing from
NCTC-2472 cells) induced pain resulted in severe spinal
astrogliosis without activation of microglia, while sciatic
nerve injury led to a transient activation of microglia
and sustained astrogliosis [28]. These observations might
indicate that development of hypersensitivity and astro-
cyte activation in CIP models could take place independ-
ently of microglial activation. Actually, the activation of
microglia does not appear earlier than activation of
astrocyte in this and another reported CIP model [5].
However, in the present study, minocycline (an inhibitor
of microglia) reduced the allodynia during the middle
stage (day 12) of cancer pain which demonstrated that
microglia also plays an essential role in the maintenance
of sustained mechanical allodynia in the present CIP
model. The results further implied a unique sequence of
glial activation in the spinal cord in this CIP model.
Excitation of glia at one site can activate distant glia
through gap junctions and propagated calcium waves,
causing them to release pain-enhancing substances such
as proinflammatory cytokines, glutamate, nitric oxide, or
other products as well [30,31]. Therefore, the widespread
activation of glia in spinal cord was proved to be
involved in the mirror-image pain induced by neur-
opathy [32]. Actually, glial cells are well characterized
for mediating expansions of the body region from which
pain is perceived [33]. Once the spread of excitation
reaches the contralateral dorsal horn, mirror-image pain
would occur. Indeed Milligan et al. have demonstrated
that inhibiting the function of astrocyte gap junctions
could abolish sciatic inflammatory neuropathy induced
mirror-image pain [32]. In the present study, contralat-
eral spreading of both microglia and astrocyte activation
was observed in the spinal cord of rats with bilateral
allodynia induced by unilateral bone cancer. Moreover,
inhibiting glial activation produced bilateral attenuation
of allodynia. These results further indicate the important
role of glial activation in chronic pain.
Figure 6 Spinal Toll-like receptor (TLR4) is involved in bone cancer pain. (A) showing the changes of TLR4 mRNA levels in bilateral dorsal
horn of spinal cord 8 and 16 days after intra-tibial injection of PBS, Heat-killed or live Walker 256 cells. (B) Showing the blocking effect of single
intrathecal administration of naloxone (60 μg) on elevated spinal IL-1β and TNF-α mRNA expression induced by intra-tibial inoculation of Walker
256 cells. (C) Anti-allodynic effects induced by single intrathecal administration of naloxone (60 μg). On the day 8 after Walker 256 inoculation,
naloxone (60 μg), a nonsteroselective TLR4 antagonist, significantly increased the mechanical thresholds to von Frey hair stimulation 45, 135 mins
after i.t. treatment. &&p< 0.01 vs. normal rats; *p< 0.05, **p< 0.01 vs. Walker 256 inoculated rats; #p< 0.05, ##p< 0.01 vs. normal saline
treatment.
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that in the CNS, TLR4 is almost exclusively expressed
by microglia [34,35]. In this study, upregulation of
TLR4 mRNA in bilateral spinal dorsal horn at 8 and
16 days after cancer cell-inoculation was observed. Our
preliminary data from flow cytometric analysis showed
that TLR4 expressed on microglia surface was increased
from 4.1% in normal rats to 5.6% Walker 256 inocu-
lated rats (data not shown). It has been reported that
naloxone can effectively inhibit microglial activation
and the production of TNF-α and IL-1β in response to
activation of the TLR signaling pathway [25]. In
addition, naloxone is now widely used as nonstereose-
lective TLR4 signaling pathway blocker in the study of
the TLR4 [15,24,36]. Hutchinson et al. reported that i.t.
delivery of neuronally inactive naloxone (60 μg), a novel
toll-like receptor (TLR) 4 antagonist, can reverse thechronic constriction injury (CCI)-induced neuropathic
pain in rats. Further histochemical analysis showed that
sustained i.t. delivery of neuronally inactive naloxone
produced suppression of CD11b/c while they showed
no effect on GFAP expression in rats with CCI induced
neuropathic pain. Interestingly, i.t. naloxone signifi-
cantly attenuated the bilateral allodynia and blocked the
increased level of spinal TNF-α and IL-1β mRNA
induced by CIP, indicating that TLR4 might contribute
to the microglia activation in the present study. This is
very consistent with the results from previous studies
[25,36-38]. Based on the pain relieving effect and rever-
sal of cytokines production by naloxone and the previ-
ous reports [24,25,36], we propose that the analgesic
effect is through glial inactivation by its action as a
TLR4 antagonist. Moreover, our recent study showed
that TLR2 expression were also elevated in spinal cord
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of TLR2 and even other TLRs in cancer induced pain
similar to what has been observed in neuropathic pain
[18,39,40]. To date, very few endogenous ligand(s)
that initiate the TLR4 signaling pathway in the CNS
post-nerve injury or cancer development have been
identified [41,42]. Further studies searching for the en-
dogenous ligands for TLRs in cancer induced pain will
shed light on finding new therapeutic targets for con-
trolling cancer induced pain.
Conclusion
The present study revealed a complicated condition of
neuroinflammation in spinal cord with sustained, robust
and bilateral activation of both microglia and astrocytes,
which critically contributed to the maintenance of the
bilateral allodynia in CIP. Our findings also indicate that
the spinal TLR4 signaling pathway might play an im-
portant role in the observed sustained glial activation.
Material and methods
Animals
Female Wistar rats weighing 140-160 g were purchased
from Shanghai Laboratory Animal Center, Chinese
Academy Sciences. Rats were housed in temperature-
controlled (24 ± 0.5°C) and light-controlled (12:12 h al-
ternating light-dark cycle) room with free access to food
and water. All experimental procedures were approved
by the Animal Care and Use Committee (ACUC) of
Fudan University, and were consistent with the NIH’s
Guide for the Care and Use of Laboratory Animals and
the Ethical Issues of the IASP [43].
Inducement for cancer induced pain
According to the previous reports [7,44], the procedure
for the inducement of caner induced pain was as follows.
Briefly, Walker 256 rat mammary gland carcinoma cells
were collected from cancerous ascitic fluid (derived from
Wistar rat, Shanghai Institute of Biomedical Engineer-
ing). The cells were washed with PBS, counted using a
haemocytometer and diluted to a final concentration of
1 × 108 cells/ml PBS solution. For the sham group, heat-
killed Walker 256 cells were prepared in the same final
concentrations for injection and boiled for 5 min. The
rats were anesthetized with sodium pentobarbital
(50 mg/kg, i.p.) for surgery. Four microliter of carcinoma
cells (4 × 105), heat-killed carcinoma cells (sham group)
in 4 μl of PBS, or 4 μl of PBS only (vehicle group) were
slowly injected into the tibia cavity by using a 10 μl
microinjection syringe with 23-gauge needle. The syr-
inge was left in place for an additional 2 min to prevent
the carcinoma cells from leaking out along the injection
track. All animals were allowed to recover from the sur-
gery for 3 days prior to any experimentation.Bone radiological detection and bone histology
Consistent with previous reports [7], to assess the tibia
bone destruction by tumor, rats were placed on a clear
plane plexiglass, exposed to an X-ray source under so-
dium pentobarbital anesthesia on day 20 after Walker
256 inoculation, and tibia bone radiographs were per-
formed using E-COM Digital Radiographer System (E-
COM Technology Co. LTD., Guangdong, China).
For bone histology, rats were transcardially perfused
with 300 ml of 0.9% normal saline followed with 300 ml
4% paraformaldehyde after being anesthetized with an
overdose of sodium pentobarbital. Tibia bones were
removed and decalcified in decalcifying solution for
24 h. The bones were rinsed, dehydrated, and then em-
bedded in paraffin, cut into 7 μm cross-sections using a
rotary microtome (Reichert-Jung 820, Cambridge Instru-
ments GmbH, Germany), and stained with hematoxylin
and eosin to visualize the extent of tumor infiltration
and bone destruction.
Von Frey test for mechanical allodynia
Mechanical allodynia was measured as the hind paw
withdrawal response to von Frey hair stimulation
according to the up-down method [45]. Animals were
placed in a plastic cage (26 × 20 × 14 cm3) with a plexi-
glass floor (containing 1.5 mm diameter holes in a 5 mm
grid of perpendicular rows). Testing was performed by
an observer blind with respect to group. After 15 min
accommodation, an ascending series of von Frey hairs
(0.40, 0.60, 1.4, 2.0, 4.0, 6.0, 8.0 and 15.0 g) (Stoelting,
Wood Dale, Illinois, USA) were applied perpendicular to
the mid-plantar surface of hind paw. Each hair was held
about 1 ~ 2 s, with a 10-min interval. A trial began with
the application of the 2.0 g hair. A positive response was
defined as a withdrawal of hind paw upon the stimulus.
Whenever a positive response to a stimulus occurred,
the next lower hair was applied, and whenever a negative
response occurred, the next higher hair was applied. The
testing consisted of five more stimuli after the first
change in response occurred, and the pattern of re-
sponse was converted to a 50% von Frey threshold using
the method described previously [45].
Hargreaves’ test for thermal hyperalgesia
The paw withdrawal latency (PWL) to radiant heat was
examined for evidence of heat hyperalgesia using the
Model 390 Paw Stimulator Analgesia Meter (IITC/Life
Science Instruments, USA) [46]. The rats were placed
beneath an inverted, clear plastic cage upon an elevated
floor of window glass. After 30 min adaptation, radiant
heat was applied to the plantar surface of each paw until
the animal lifted its paw from the glass. The time from
onset of radiant heat application to withdrawal of the
rat’s hind paw was defined as the PWL. The radiant heat
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PWL around 10~ 12 s in normal rats. A cut-off time
was defined 20 s to prevent tissue damage. Both hind
paws were tested independently with a 10-min interval.
The average of the three trials was then determined.
Testing was performed blind with respect to group.
Intrathecal drug administration
In order to observe the role of spinal astrocyte and
microglia in CIP rats, fluorocitrate (FC, 1 nmol in 10 μl;
Sigma) or minocycline hydrochloride (100 μg in 10 μl;
Sigma) was administrated via lumbar puncture [47,48].
Fluorocitrate, a reversible glial metabolic inhibitor, acts
by inhibiting aconitase, an enzyme of the Krebs energy
cycle of glia but not neurons. Fluorocitrate was dissolved
initially in 2 M HCl and then diluted in sterile 10 mM
PBS to attain a final concentration, pH 6.0 at the time of
testing. Minocycline hydrochloride, a second-generation
semi-synthetic tetracycline derivative, was used to inhibit
microglia activation. Minocycline hydrochloride was dis-
solved in saline freshly before use and heated briefly in a
water bath until completely dissolved into the clear solu-
tion, then neutralized to pH (7.2-7.4) by 0.1 N NaOH.
Based on previous studies showing that naloxone could
block the TLR4 signaling pathway [14,15,24,49], nalox-
one (Sigma, St. Louis, USA) was intrathecally adminis-
tered as a non-stereoselective TLR4 signaling blocker to
determine the role of TLR4 on CIP in this study. During
lumbar puncture [50], the rats were anesthetized with
2% isoflurane in air via a nose cone. After the lumbar re-
gion was disinfected with 70% v/v ethanol, a 29-gauge
microinjection syringe needle filled with 10 μl drug was
inserted via L5-6 interspace. The correct subarachnoid
positioning of the tip of the needle was verified by a tail-
or paw-flick response.
Immunohistochemistry
Three to five animals of each group were used for
immunohistochemical study. The rats were given an
overdose of sodium pentobarbital and transcardially per-
fused with 300 ml 0.9% normal saline followed with
300 ml 4% paraformaldehyde in 0.1 M phosphate buffer
(PB, pH 7.4). The L4-6 segments of spinal cord were
removed, and then immersed from 10-30% gradient su-
crose in PB for 24-48 h at 4°C. Transverse spinal sec-
tions (Free-floating, 25 μm) were cut in a cryostat
(Reichert-Jung, German) for immunohistochemistry ana-
lysis. In order to distinguish the two sides of spinal cord,
a thin needle was used to drill a hole in the contralateral
side of the spinal cord before cutting on a freezing
microtome. Sections were rinsed in 0.01 M PBS (pH 7.4)
three times for 15 minutes, preincubated with 10% nor-
mal goat serum in 0.01 M PBS with 0.3% Triton-X-100
for 2 h at room temperature (RT), incubated over nightat 4°C after 1 h at RT with mouse anti-glial fibrillary
acidic protein (GFAP, 1:1000, Lab Vision) or mouse anti-
OX-42 (1:1000, Chemicon) primary antibody. The
sections were washed three times in 0.01 M PBS and
incubated for 2 h at RT with biotinylated goat anti-
mouse IgG (1:200, Santa Cruz). Then, the sections were
washed three times in 0.01 M PBS and incubated for 1 h
with avidin-biotin-peroxidase complex (1:200, Vector
Laboratories) at RT. 0.05% 3,3-diaminobenzidine (DAB,
Sigma) and 0.03% H2O2 were used to reveal the pres-
ence of the GFAP- or OX-42-positive signals following
washed three times in PBS. The sections were then
mounted, air-dried, dehydrated in alcohol in a graded
manner, cleared in xylenes and cover slipped. To assess
staining specificity, the primary antibody was omitted as
negative control and showed no signs of immunohisto-
chemical reaction. The stained sections were examined
with a Leica Q500IW image analysis system. For GFAP
or OX-42 immunostaining, positively labeled identified
for automated counting using Image Measurement 1.0.
Quantification of GFAP or OX-42 immunoreactivity was
performed by calculating the percentages of immunos-
taining ([number of pixels of positively labeled objects
within the fixed area]/[number of pixels within the same
fixed area] × 100) [51]. Labeling was quantified in the
selected area of spinal cord slices stained with diamino-
benzidine, with four slices quantified per animal. The in-
vestigator responsible for image analysis was blind to the
experimental condition of each rat.
RT-PCR analysis
Three or five animals of each group were used for RT-
PCR analysis. Total RNA was extracted from L4-6 seg-
ments of spinal cord by using the Trizol reagent
(Invitrogen, CA, USA) according to manufacture’s in-
struction. The quality of RNA was assessed by agarose
gel electrophoresis. 1 μg of total RNA was reversely
transcribed into cDNA for RT-PCR. Negative control
reactions were run without RNA to test for contamin-
ation of reagents. Oligonucleotide primers were chosen
on the basis of rat nucleotide sequences in the GenBank
database, and according to previously published
sequences [52,53]. The size and sequence of each primer
and number of cycles used are given in Table 1.
Polymerase chain reaction (PCR) amplification was
performed with 1 U of Taq DNA polymerase (Promega),
2.5 mM dNTP mix and 1 μM of each primer, using 1 μl
of the RT reaction product as template. After amplifica-
tion, the products were electrophoresised in 2% agarose
gel, visualized by ethidium bromide staining and scanned
with ultraviolet transilluminator (GDS 8000, Gene Tools
from Syngene Software, UK). Bands were analyzed using
GeneSnap Image Analysis Software (Syngene, UK). The
relative amount of each mRNA was normalized to the





Primers PCR condition (temperature/time) Predicted
size (bp)Denature Anneal Extend
NM031144 β-actin Forward: 5’-tcaggtcatcactatcggcaat-3’ 94 °C/45 s 58 °C/45 s 72 °C/1 min 432
Reverse: 5’-aaagaaagggtgtaaaacgca-3’
NM031512 IL-1β Forward: 5’-atgagagcatccagcttcaaatc-3’ 94 °C/45 s 58 °C/45 s 72 °C/1 min 328
Reverse: 5’-gcttatgttctgtccattgaggt -3’
NM012589 IL-6 Forward: 5’-gacaaagccagagtccttca-3’ 94 °C/45 s 58 °C/45 s 72 °C/1 min 229
Reversed 5’-actaggtttgccgagtagac-3’
X66539 TNF-α Forward: 5’-cgagatgtggaactggcaga-3’ 94 °C/45 s 58 °C/45 s 72 °C/1 min 256
Reverse: 5’-ctacgggcttgtcactcga-3’
NM019178 TLR4 Forward: 5’-gccggaaagttattgtggtg-3’ 94 °C/45 s 58 °C/45 s 72 °C/1 min 203
Reverse: 5’-ccactcgaggtaggtgttt-3’
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sented as ratio of the signal intensity of examined gene
vs. normal control. To avoid the genomic DNA contam-
ination for RNA preparation, 1 ug of total RNA was
used for PCR amplification and no PCR bands were
found in the test.
Multiplex assay for cytokine expression
Four animals of each group were used for cytokine ex-
pression by using Bio-Plex analysis. The L4-6 segments
of spinal cord were removed from the rats under deep
anesthesia with an over dose of sodium pentobarbital.
According to the instruction supported by Shanghai
Miaotong Bio-Tech. Company, fifty μl of total protein
extracted from the lumber enlargement were used for
the cytokine analysis. Finally, the cytokine level was read
by Bio-Plex 200 System (Bio-Rad Laboratories, Inc).
Statistical analysis
Data were presented as mean ± S.E.M and were analyzed
for statistical significance by one-way analysis of vari-
ance (ANOVA) followed by Newman-Keuls test or chi-
square test based on necessary, using the Statistical
Package for the Social Sciences (SPSS) statistical soft-
ware. P< 0.05 was considered statistically significant.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YQ contributed to the conception and design of the experiments. GC
contributed to manuscript drafting and revising. QL, XW and Xiu contributed
to the animal behavior, QL and WL contributed to the PCR and
Immunohistochemistry. CJ contributed to the Multi-Plex analysis. All authors
read and approved the manuscript.
Acknowledgments
The projects was financially supported by The National Natural Science
Foundation (No. 30970975; 81072875; 31000495; 81171045; 31121061;
31070973), and Excellent Doctoral Graduate Research Program of Fudan
University and Doctoral Fund of Ministry of Education of China
(20100071110042). We thank Dr. Annemieke Kavelaars from UIUC for herrevision of the manuscript and relevant suggestions. The authors declare
that there are no conflicts of interest related to the study.
Received: 25 March 2012 Accepted: 2 May 2012
Published: 20 May 2012References
1. Schwei MJ, Honore P, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine
ML, Clohisy DR, Mantyh PW: Neurochemical and cellular reorganization of
the spinal cord in a murine model of bone cancer pain. J Neurosci 1999,
19:10886–10897.
2. Medhurst SJ, Walker K, Bowes M, Kidd BL, Glatt M, Muller M, Hattenberger
M, Vaxelaire J, O'Reilly T, Wotherspoon G, et al: A rat model of bone cancer
pain. Pain 2002, 96:129–140.
3. Sasamura T, Nakamura S, Iida Y, Fujii H, Murata J, Saiki I, Nojima H, Kuraishi
Y: Morphine analgesia suppresses tumor growth and metastasis in a
mouse model of cancer pain produced by orthotopic tumor inoculation.
Eur J Pharmacol 2002, 441:185–191.
4. Sabino MA, Luger NM, Mach DB, Rogers SD, Schwei MJ, Mantyh PW:
Different tumors in bone each give rise to a distinct pattern of skeletal
destruction, bone cancer-related pain behaviors and neurochemical
changes in the central nervous system. Int J Cancer 2003, 104:550–558.
5. Zhang RX, Liu B, Wang L, Ren K, Qiao JT, Berman BM, Lao L: Spinal glial
activation in a new rat model of bone cancer pain produced by prostate
cancer cell inoculation of the tibia. Pain 2005, 118:125–136.
6. Watkins LR, Milligan ED, Maier SF: Glial activation: a driving force for
pathological pain. Trends Neurosci 2001, 24:450–455.
7. Mao-Ying QL, Zhao J, Dong ZQ, Wang J, Yu J, Yan MF, Zhang YQ, Wu GC,
Wang YQ: A rat model of bone cancer pain induced by intra-tibia
inoculation of Walker 256 mammary gland carcinoma cells. Biochem
Biophys Res Commun 2006, 345:1292–1298.
8. Watkins LR, Hutchinson MR, Milligan ED, Maier SF: "Listening" and "talking"
to neurons: implications of immune activation for pain control and
increasing the efficacy of opioids. Brain Res Rev 2007, 56:148–169.
9. Tanga FY, Nutile-McMenemy N, DeLeo JA: The CNS role of Toll-like
receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl
Acad Sci U S A 2005, 102:5856–5861.
10. DeLeo JA, Tanga FY, Tawfik VL: Neuroimmune activation and
neuroinflammation in chronic pain and opioid tolerance/hyperalgesia.
Neuroscientist 2004, 10:40–52.
11. Obata K, Katsura H, Miyoshi K, Kondo T, Yamanaka H, Kobayashi K, Dai Y,
Fukuoka T, Akira S, Noguchi K: Toll-like receptor 3 contributes to spinal
glial activation and tactile allodynia after nerve injury. J Neurochem 2008,
105:2249–2259.
12. Shi XQ, Zekki H, Zhang J: The role of TLR2 in nerve injury-induced
neuropathic pain is essentially mediated through macrophages in
peripheral inflammatory response. Glia 2011, 59:231–241.
13. Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F, Costa B: Glial
TLR4 receptor as new target to treat neuropathic pain: efficacy of a new
Mao-Ying et al. Molecular Brain 2012, 5:16 Page 11 of 11
http://www.molecularbrain.com/content/5/1/16receptor antagonist in a model of peripheral nerve injury in mice. Glia
2008, 56:1312–1319.
14. Watkins LR, Hutchinson MR, Rice KC, Maier SF: The "toll" of opioid-induced
glial activation: improving the clinical efficacy of opioids by targeting
glia. Trends Pharmacol Sci 2009, 30:581–591.
15. Liu L, Coller JK, Watkins LR, Somogyi AA, Hutchinson MR: Naloxone-
precipitated morphine withdrawal behavior and brain IL-1beta
expression: comparison of different mouse strains. Brain Behav Immun
2011, 25:1223–1232.
16. Aderem A, Ulevitch RJ: Toll-like receptors in the induction of the innate
immune response. Nature 2000, 406:782–787.
17. Re F, Strominger JL: Toll-like receptor 2 (TLR2) and TLR4 differentially
activate human dendritic cells. J Biol Chem 2001, 276:37692–37699.
18. Kim D, Lee S, Lee SJ: Toll-like receptors in peripheral nerve injury and
neuropathic pain. Curr Top Microbiol Immunol 2009, 336:169–186.
19. Hacker H, Vabulas RM, Takeuchi O, Hoshino K, Akira S, Wagner H: Immune
cell activation by bacterial CpG-DNA through myeloid differentiation
marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
J Exp Med 2000, 192:595–600.
20. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H,
Wagner H: Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4
to activate the toll/interleukin-1 receptor signaling pathway in innate
immune cells. J Biol Chem 2001, 276:31332–31339.
21. Ohashi K, Burkart V, Flohe S, Kolb H: Cutting edge: heat shock protein 60
is a putative endogenous ligand of the toll-like receptor-4 complex. J
Immunol 2000, 164:558–561.
22. Smiley ST, King JA, Hancock WW: Fibrinogen stimulates macrophage
chemokine secretion through toll-like receptor 4. J Immunol 2001,
167:2887–2894.
23. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat
N, Kashiwagi M, Orend G, et al: Tenascin-C is an endogenous activator of
Toll-like receptor 4 that is essential for maintaining inflammation in
arthritic joint disease. Nat Med 2009, 15:774–780.
24. Lewis SS, Hutchinson MR, Rezvani N, Loram LC, Zhang Y, Maier SF, Rice KC,
Watkins LR: Evidence that intrathecal morphine-3-glucuronide may cause
pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta.
Neuroscience 2010, 165:569–583.
25. Shen D, Cao X, Zhao L, Tuo J, Wong WT, Chan CC: Naloxone ameliorates
retinal lesions in Ccl2/Cx3cr1 double-deficient mice via modulation of
microglia. Invest Ophthalmol Vis Sci 2011, 52:2897–2904.
26. Mercadante S: Malignant bone pain: pathophysiology and treatment.
Pain 1997, 69:1–18.
27. Ripamonti C, Fulfaro F: Malignant bone pain: pathophysiology and
treatments. Curr Rev Pain 2000, 4:187–196.
28. Hald A, Nedergaard S, Hansen RR, Ding M, Heegaard AM: Differential
activation of spinal cord glial cells in murine models of neuropathic and
cancer pain. Eur J Pain 2009, 13:138–145.
29. Watkins LR, Maier SF: Implications of immune-to-brain communication for
sickness and pain. Proc Natl Acad Sci U S A 1999, 96:7710–7713.
30. Hassinger TD, Atkinson PB, Strecker GJ, Whalen LR, Dudek FE, Kossel AH,
Kater SB: Evidence for glutamate-mediated activation of hippocampal
neurons by glial calcium waves. J Neurobiol 1995, 28:159–170.
31. Parri HR, Gould TM, Crunelli V: Spontaneous astrocytic Ca2+ oscillations in
situ drive NMDAR-mediated neuronal excitation. Nat Neurosci 2001,
4:803–812.
32. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S,
Tracey K, Martin D, Maier SF, Watkins LR: Spinal glia and proinflammatory
cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 2003,
23:1026–1040.
33. Hansson E: Could chronic pain and spread of pain sensation be induced
and maintained by glial activation? Acta Physiol (Oxf ) 2006, 187:321–327.
34. Olson JK, Miller SD: Microglia initiate central nervous system innate and
adaptive immune responses through multiple TLRs. J Immunol 2004,
173:3916–3924.
35. Laflamme N, Rivest S: Toll-like receptor 4: the missing link of the cerebral
innate immune response triggered by circulating gram-negative
bacterial cell wall components. FASEB J 2001, 15:155–163.
36. Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, Sholar PW, Patel
SJ, Crysdale NY, Harrison JA, Maier SF, et al: Non-stereoselective reversal of
neuropathic pain by naloxone and naltrexone: involvement of toll-like
receptor 4 (TLR4). Eur J Neurosci 2008, 28:20–29.37. Lan LS, Ping YJ, Na WL, Miao J, Cheng QQ, Ni MZ, Lei L, Fang LC, Guang RC,
Jin Z, Wei L: Down-regulation of Toll-like receptor 4 gene expression by
short interfering RNA attenuates bone cancer pain in a rat model. Mol
Pain 2010, 6:2.
38. Liu S, Yang J, Wang L, Jiang M, Qiu Q, Ma Z, Liu L, Li C, Ren C, Zhou J, Li W:
Tibia tumor-induced cancer pain involves spinal p38 mitogen-activated
protein kinase activation via TLR4-dependent mechanisms. Brain Res
2010, 1346:213–223.
39. Guo LH, Schluesener HJ: The innate immunity of the central nervous
system in chronic pain: the role of Toll-like receptors. Cell Mol Life Sci
2007, 64:1128–1136.
40. Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, Choi SY, Park K, Kim JS, Akira
S, et al: A critical role of toll-like receptor 2 in nerve injury-induced spinal
cord glial cell activation and pain hypersensitivity. J Biol Chem 2007,
282:14975–14983.
41. Hutchinson MR, Ramos KM, Loram LC, Wieseler J, Sholar PW, Kearney JJ,
Lewis MT, Crysdale NY, Zhang Y, Harrison JA, et al: Evidence for a role of
heat shock protein-90 in toll like receptor 4 mediated pain
enhancement in rats. Neuroscience 2009, 164:1821–1832.
42. Hutchinson MR, Lewis SS, Coats BD, Rezvani N, Zhang Y, Wieseler JL,
Somogyi AA, Yin H, Maier SF, Rice KC, Watkins LR: Possible involvement of
toll-like receptor 4/myeloid differentiation factor-2 activity of opioid
inactive isomers causes spinal proinflammation and related behavioral
consequences. Neuroscience 2010, 167:880–893.
43. Zimmermann M: Ethical guidelines for investigations of experimental
pain in conscious animals. Pain 1983, 16:109–110.
44. Liu S, Liu WT, Liu YP, Dong HL, Henkemeyer M, Xiong LZ, Song XJ: Blocking
EphB1 receptor forward signaling in spinal cord relieves bone cancer
pain and rescues analgesic effect of morphine treatment in rodents.
Cancer Res 2011, 71:4392–4402.
45. Dixon WJ: Efficient analysis of experimental observations. Annu Rev
Pharmacol Toxicol 1980, 20:441–462.
46. Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive
method for measuring thermal nociception in cutaneous hyperalgesia.
Pain 1988, 32:77–88.
47. Sun S, Chen WL, Wang PF, Zhao ZQ, Zhang YQ: Disruption of glial
function enhances electroacupuncture analgesia in arthritic rats. Exp
Neurol 2006, 198:294–302.
48. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF,
Watkins LR: Minocycline attenuates mechanical allodynia and
proinflammatory cytokine expression in rat models of pain facilitation.
Pain 2005, 115:71–83.
49. Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX,
Slivka PF, Coats BD, Rezvani N, Wieseler J, et al: Evidence that opioids may
have toll-like receptor 4 and MD-2 effects. Brain Behav Immun 2010,
24:83–95.
50. Olmarker K: Puncture of a lumbar intervertebral disc induces changes in
spontaneous pain behavior: an experimental study in rats. Spine (Phila Pa
1976) 2008, 33:850–855.
51. Ito N, Obata H, Saito S: Spinal microglial expression and mechanical
hypersensitivity in a postoperative pain model: comparison with a
neuropathic pain model. Anesthesiology 2009, 111:640–648.
52. Wang J, Zhao H, Mao-Ying QL, Cao XD, Wang YQ, Wu GC:
Electroacupuncture downregulates TLR2/4 and pro-inflammatory
cytokine expression after surgical trauma stress without adrenal glands
involvement. Brain Res Bull 2009, 80:89–94.
53. Wang J, Li J, Sheng X, Zhao H, Cao XD, Wang YQ, Wu GC: Beta-
adrenoceptor mediated surgery-induced production of pro-inflammatory
cytokines in rat microglia cells. J Neuroimmunol 2010, 223:77–83.
doi:10.1186/1756-6606-5-16
Cite this article as: Mao-Ying et al.: Robust spinal neuroinflammation
mediates mechanical allodynia in Walker 256 induced bone cancer rats.
Molecular Brain 2012 5:16.
